Imatinib (Sti571, Gleevec (Tm)) Achieves Prolonged Survival In Patients With Accelerated Phase Ph Plus Chronic Myeloid Leukemia (Cml-Ap): Up To 36 Months Follow-Up Of A Phase Ii Study.M Talpaz,Rt Silver,Bj Druker,R Paquette,Jm Goldman,C Gambacorti-Passerini,F Guilhot,Ca Schiffer,T Fischer, Sg O'Brien,Mw Deininger,A Hochhaus,Og Ottmann,A Gratwohl, S Tura, M Baccarani,Rm Stone,J Reiffers, Ae Bolton,I GathmannBLOOD（2002）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
